These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22978309)

  • 1. Patients with asthma benefit from concomitant therapy with cineole: a placebo-controlled, double-blind trial.
    Worth H; Dethlefsen U
    J Asthma; 2012 Oct; 49(8):849-53. PubMed ID: 22978309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial.
    Worth H; Schacher C; Dethlefsen U
    Respir Res; 2009 Jul; 10(1):69. PubMed ID: 19624838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
    Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acupoint sticking therapy for treatment of bronchial asthma: a multicenter controlled randomized clinical trial].
    Yao H; Tong J; Zhang PD; Tao JP; Li JX
    Zhongguo Zhen Jiu; 2009 Aug; 29(8):609-12. PubMed ID: 19947260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
    Li JS; Li SY; Yu XQ; Xie Y; Wang MH; Li ZG; Zhang NZ; Shao SJ; Zhang YJ; Zhu L; Guo LX; Bai YP; Wang YF
    J Ethnopharmacol; 2012 Jun; 141(2):584-91. PubMed ID: 21911051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory properties of the monoterpene 1.8-cineole: current evidence for co-medication in inflammatory airway diseases.
    Juergens UR
    Drug Res (Stuttg); 2014 Dec; 64(12):638-46. PubMed ID: 24831245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiinflammatory effects of euclyptol (1.8-cineole) in bronchial asthma: inhibition of arachidonic acid metabolism in human blood monocytes ex vivo.
    Juergens UR; Stöber M; Schmidt-Schilling L; Kleuver T; Vetter H
    Eur J Med Res; 1998 Sep; 3(9):407-12. PubMed ID: 9737886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
    Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
    Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.
    Levin TR; Sperling RM; McQuaid KR
    Am J Gastroenterol; 1998 Jul; 93(7):1060-3. PubMed ID: 9672330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.
    Okamoto LJ; Noonan M; DeBoisblanc BP; Kellerman DJ
    Ann Allergy Asthma Immunol; 1996 May; 76(5):455-61. PubMed ID: 8630720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
    Boulet LP; Turcotte H; Prince P; Lemière C; Olivenstein R; Laprise C; Larivée P; Bégin P; Laviolette M
    Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S; Liu N; Dass SB; Reiss TF
    J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma.
    Wasfi YS; Villarán C; de Tilleghem Cle B; Smugar SS; Hanley WD; Reiss TF; Knorr BA
    Respir Med; 2012 Jan; 106(1):34-46. PubMed ID: 21945511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.